NCT02223208 2025-12-02FIL_PTCL13Fondazione Italiana Linfomi - ETSPhase 1/2 Active not recruiting89 enrolled
NCT05749549 2024-08-07Phase I/IIa Study of BR1733 in Subjects With Advanced CancersShanghai Blueray Biopharma Co., Ltd.Phase 1/2 Active not recruiting191 enrolled
NCT03547700 2021-01-19Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)Big Ten Cancer Research ConsortiumPhase 1/2 Active not recruiting11 enrolled